Posted on March 17, 20263/17/26
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
Posted on March 16, 20263/16/26
Why women’s health is at an inflection point and why commercialization models must advance
Posted on February 26, 20262/26/26
Building a scalable GLP-1 care model
Posted on February 26, 20262/26/26
Creative matters: Connecting with the rare disease community
Posted on February 18, 20262/18/26
How uniting tech and human touch can make a difference for rare disease patients
Posted on February 10, 20262/10/26
Inside the Shifting Role of Pharma 3PLs: Resilience, Regulation, and the Road Ahead
Posted on January 29, 20261/29/26
Lessons Learned From a Commercial Launch: Q&A with Greg Skalicky
Posted on January 28, 20261/28/26
Bringing a Breakthrough Rare Disease Product to Patients: Q&A with Helen Sabzevari
Posted on January 22, 20261/22/26
PM360 2025 Innovative ARTIFICIAL INTELLIGENCE: EVERSANA’s AI Agency Platform
Posted on December 16, 202512/16/25